Pomerantz Law Firm Alerts Investors on Park Ha Biological Technology Class Action Timeline

Investor Alert: Park Ha Biological Technology Class Action

In an urgent announcement, Pomerantz LLP notifies investors regarding potential actions related to their investments in Park Ha Biological Technology Co., Ltd. Those who have incurred financial losses are being advised on the next steps amid a class action lawsuit.

Background on Park Ha Biological Technology

Park Ha, a company listed on the NASDAQ under the ticker symbol BYAH, has recently come under scrutiny due to allegations pertaining to securities fraud and other illicit business practices. This is particularly concerning for individuals who have acquired Park Ha securities during the Class Period. Investors have until September 28, 2026, to request to be appointed as Lead Plaintiff to represent their interests in court proceedings.

Class Action Details

The suit alleges that Park Ha, along with certain officers and directors, engaged in deceptive practices, leading to substantial investor losses. It specifically claims that Park Ha was ensnared in a fraudulent “pump-and-dump” scheme that manipulated stock prices, greatly inflating its value without any substantial corporate backing. After the company’s initial public offering (IPO), Park Ha’s stock skyrocketed from $4.00 to an extraordinary high of $41.49 on July 7, 2025. This dramatic rise occurred despite a conspicuous absence of business developments or financial justifications, raising red flags among investors and regulatory bodies alike.

Allegations of Stock Manipulation

Investigative reports point towards a conspiracy where social media was utilized to spread misinformation regarding Park Ha, drawing in unsuspecting retail investors. Fake financial advisors purportedly made fraudulent claims in various online platforms, culminating in an artificial buying frenzy that misled numerous investors. The fallout from these operations has been devastating, leaving many investors stranded as the stock price eventually collapsed back to reality.

Support for Affected Investors

Pomerantz LLP, recognized for its commitment to protecting the rights of investors, stands ready to assist those affected. Investors wishing to explore participation in this class action can reach out to Danielle Peyton directly via her email at [email protected] or contact her at 646-581-9980 (toll-free at Ext. 7980). For those reaching out electronically, it is recommended to provide a mailing address, phone number, and details regarding the number of shares purchased to facilitate the process.

Firm Background

Pomerantz LLP has carved a noteworthy niche in corporate law, securities litigation, and antitrust class actions. Established by the late Abraham L. Pomerantz, known as the pioneer in class action cases, the firm has successfully recovered significant damages for victims of corporate misconduct for over 85 years. Their legacy continues to influence the fight against securities fraud and aims to safeguard shareholder rights across the board.

Conclusion

As the legal battle unfolds, affected investors are encouraged to stay informed and consider their options. The timeframe to engage in this pivotal class action is rapidly approaching, and timely action could be crucial in reclaiming potential losses incurred through Park Ha Biological Technology. For further information and specifics regarding joining the lawsuit and deadlines, visit www.pomerantzlaw.com.

This alert serves as a critical reminder for investors to exercise vigilance and seek guidance if they feel wronged. With Pomerantz at the helm, stakeholders are in capable hands as they navigate these choppy waters of corporate litigation.